SiRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection

Journal of Drug Targeting

Volumn 16, Issue 2, 2008, Pages 140-148

  Chen, Yong ^a,b   Mahato, Ram ^b  

^a Huaian 4th People's Hospital   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

HBsAg expression; HBV replication; Hepatitis B virus; ShRNA; SiRNA

Indexed keywords

DNA; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; LIPOFECTAMINE; MESSENGER RNA; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANTIGEN EXPRESSION; ARTICLE; CELL STRAIN HEPG2; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; RNA SEQUENCE; VIRUS INHIBITION; VIRUS REPLICATION;

APOPTOSIS; CELL LINE, TUMOR; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GENE TARGETING; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; PLASMIDS; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, RNA; TRANSFECTION; VIRUS REPLICATION;

EID: 39449092763     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701878750     Document Type: Article

References (38)

1. Barnaba, V., Franco, A., Alberti, A., Benvenuto, R. and Balsano, F. (1990) Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature, 345:6272, pp. 258-260.
2. Brummelkamp, TR, Bernards, R. and Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science, 296:5567, pp. 550-553.
3. Chen, WN, Oon, CJ, Leong, AL, Koh, S. and Teng, SW (2000) Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance. Biochem Biophys Res Commun, 276:3, pp. 885-892.
4. Cheng, TL, Chang, WW, Su, IJ, Lai, MD, Huang, W., Lei, HY and Chang, WT (2005) Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference. Biochem Biophys Res Commun, 336:3, pp. 820-830.
5. Chu, CM, Karayiannis, P., Fowler, MJ, Monjardino, J., Liaw, YF and Thomas, HC (1985) Natural history of chronic hepatitis B virus infection in Taiwan: Studies of hepatitis B virus DNA in serum. Hepatology, 5:3, pp. 431-434.
6. Chu, CM and Liaw, YF (1997) Natural history of chronic hepatitis B virus infection: An immunopathological study. J Gastroenterol Hepatol, 12:9, pp. S218-S222.
7. Couzin, J. (2002) Breakthrough of the year. Small RNAs make big splash. Science, 298:5602, pp. 2296-2297.
8. De Paula, D., Bentley, MV and Mahato, RI (2007) Effect of iNOS and NF-kappaB gene silencing on beta-cell survival and function. J Drug Target, 15:5, pp. 358-369.
9. Dienstag, JL, Cianciara, J., Karayalcin, S., Kowdley, KV, Willems, B., Plisek, S., Woessner, M., Gardner, S. and Schiff, E. (2003) Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology, 37:4, pp. 748-755.
10. Dunsford, HA, Sell, S. and Chisari, FV (1990) Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. Cancer Res, 50:11, pp. 3400-3407.
11. Fire, A., Xu, S., Montgomery, MK, Kostas, SA, Driver, SE and Mello, CC (1998) Potent and specific genetic interference by double-stranded RNA in C. elegans. Nature, 391:6669, pp. 806-811.
12. Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O. and Galun, E. (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther, 8:5, pp. 769-776.
13. Gou, D., Jin, N. and Liu, L. (2003) Gene silencing in mammalian cells by PCR-based short hairpin RNA. FEBS Lett, 548:1, pp. 113-118.
14. Hammond, SM, Boettcher, S., Caudy, AA, Kobayashi, R. and Hannon, GJ (2001) Argonaute2, a link between genetic and biochemical analyses of RNAi. Science, 293:5532, pp. 1146-1150.
15. Konishi, M., Wu, CH and Wu, GY (2003) Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology, 38:4, pp. 842-850.
16. Lai, CL and Wu, PC (1997) Antiviral treatment for chronic hepatitis B. Hong Kong Med J, 3:3, pp. 289-296.
17. Lau, JY and Wright, TL (1993) Molecular virology and pathogenesis of hepatitis B. Lancet, 342:8883, pp. 1335-1340.
18. Lee, WM (1997) Hepatitis B virus infection. N Engl J Med, 337:24, pp. 1733-1745.
19. Lok, AS, Karayiannis, P., Jowett, TP, Fowler, MJ, Farci, P., Monjardino, J. and Thomas, HC (1985) Studies of HBV replication during acute hepatitis followed by recovery and acute hepatitis progressing to chronic disease. J Hepatol, 1:6, pp. 671-679.
20. McCaffrey, AP, Nakai, H., Pandey, K., Huang, Z., Salazar, FH, Xu, H., Wieland, SF, Marion, PL and Kay, MA (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol, 21:6, pp. 639-644.
21. Milich, DR, McLachlan, A., Thornton, GB and Hughes, JL (1987) Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature, 329:6139, pp. 547-549.
22. Miyagishi, M. and Taira, K. (2002) U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol, 20:5, pp. 497-500.
23. Montgomery, MK and Fire, A. (1998) Double-stranded RNA as a mediator in sequence-specific genetic silencing and co-suppression. Trends Genet, 14:7, pp. 255-258.
24. Myers, JW and Ferrell, JE (2005) Silencing gene expression with dicer-generated siRNA pools. Methods Mol Biol, 309, pp. 93-196.
25. Nakamoto, Y., Guidotti, LG, Kuhlen, CV, Fowler, P. and Chisari, FV (1998) Immune pathogenesis of hepatocellular carcinoma. J Exp Med, 188:2, pp. 341-350.
26. Peng, J., Zhao, Y., Mai, J., Pang, WK, Wei, X., Zhang, P. and Xu, Y. (2005) Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties. J Gen Virol, 86, pp. 3227-3234.
27. Plasterk, RH (2002) RNA silencing: The genome's immune system. Science, 296:5571, pp. 1263-1265.
28. Rapicetta, M., Ferrari, C. and Levrero, M. (2002) Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol, 67:3, pp. 454-457.
29. Robbins, MA, Li, M., Leung, I., Li, H., Boyer, DV, Song, Y., Behlke, MA and Rossi, JJ (2006) Stable expression of shRNAs in human CD34+ progenitor cells can avoid induction of interferon responses to siRNAs in vitro. Nat Biotechnol, 24:5, pp. 566-571.
30. Shlomai, A. and Shaul, Y. (2003) Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology, 37:4, pp. 764-770.
31. Tabara, H., Grishok, A. and Mello, CC (1998) RNAi in C. elegans: Soaking in the genome sequence. Science, 282:5388, pp. 430-431.
32. Tijsterman, M. and Plasterk, RH (2004) Dicers at RISC; the mechanism of RNAi. Cell, 117:1, pp. 1-3.
33. Tipples, GA, Ma, MM, Fischer, KP, Bain, VG, Kneteman, NM and Tyrrell, DL (1996) Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology, 24:3, pp. 714-717.
34. Toshkov, I., Chisari, FV and Bannasch, P. (1994) Hepatic preneoplasia in hepatitis B virus transgenic mice. Hepatology, 20:5, pp. 1162-1172.
35. Wands, JR and Blum, HE (1991) Primary hepatocellular carcinoma. N Engl J Med, 325:10, pp. 729-731.
36. Wang, DA, Narang, AS, Kotb, M., Gaber, AO, Miller, DD, Kim, SW and Mahato, RI (2002) Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules, 3:6, pp. 1197-1207.
37. Weinberg, MS, Ely, A., Barichievy, S., Crowther, C., Mufamadi, S., Carmona, S. and Arbuthnot, P. (2007) Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Mol Ther, 15:3, pp. 534-541.
38. Yen, TS (1996) Hepadnaviral X protein: Review of recent progress. J Biomed Sci, 3:1, pp. 20-30.